Answers are grounded in this paper and cite their sources.
Focetria (Novartis) monovalent inactivated pandemic influenza vaccine corresponding to 7.5 mg of haemagglutinin (HA) antigen strain A/California/7/2009 (H1N1)v like strain (X-179A) MF59-adjuvanted between November 2009 and February 2010.The vaccine was administered intramuscularly into the deltoid muscle of the non-dominant arm on day 0. Blood samples were collected on day 0 and on day 21 to assess immunogenicity according to the Committee for Proprietary Medicinal Products (CPMP) criteria 5 ; CD4 T cell counts were also assessed on day 0 to exclude immunodeficiency.Patients or their parents recorded in a diary card the onset and severity of solicited local and systemic reactions within 7 days after the vaccine administration.We enrolled 48 CF patients with an average good pulmonary function and nutritional status.They showed normal CD4 T cell counts.All patients were assessed for safety and 33 of them for immunogenicity.There were no dropouts because of adverse reactions.The vaccine was well tolerated and no serious adverse events have been reported.All recorded symptoms were mild and shortlasting.The most frequent reported symptoms were local reactions.Seroconversion rate was satisfactory and met all the CPMP criteria.Demographics, immunogenicity and safety data are shown in table 1.In conclusion, a single 7.5 mg dose of the monovalent A/H1N1 MF59-adjuvanted vaccine results in a high rate of seroconver-sion in CF patients.These data support the current influenza vaccination strategy.The vaccine is well tolerated and the frequency of adverse events is comparable with literature data regarding other influenza vaccines.However, we studied a small cohort of young patients with an overall good nutritional and lung status.In severe malnourished CF patients, supposed to have a decreased immune response, the vaccine may not have the same efficacy.Future prospectical studies are needed to evaluate the benefits of influenza vaccines on defined clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Colombo et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: